Frequent Links
Fractures Peer-review JournalsFinancial Analysisthermodynamics-Open-Access-JournalsMinimally Invasive Spine Surgery Peer-review JournalsSinus High Impact Factor JournalsCloning ppt Research ArticlesRheumatism Review ArticlesAutoimmune Diseases Open Access Mass Media ArticlesBiohazards Ayurvedic MedicineOsteoporosis Articles open accessTranslational research Chromatography Purification High Impact Factor JournalsHormones
Levobunolol
File:Levobunolol structural formulae.png | |
Systematic (IUPAC) name | |
---|---|
(S)-5-{[3-(tert-Butylamino)-2-hydroxypropyl]oxy}-3,4-dihydronaphthalen-1(2H)-one | |
Clinical data | |
Trade names | Betagan |
AHFS/Drugs.com | monograph |
MedlinePlus | a686011 |
| |
| |
Topical (eye drops) | |
Pharmacokinetic data | |
Half-life | 20 hours |
Identifiers | |
47141-42-4 7px | |
S01ED03 | |
PubChem | CID 39468 |
DrugBank | DB01210 7px |
ChemSpider | 36089 7px |
UNII | G6317AOI7K 7px |
KEGG | D08115 7px |
ChEBI | CHEBI:6438 7px |
ChEMBL | CHEMBL1201237 7px |
Chemical data | |
Formula | C17H25NO3 |
291.385 g/mol | |
| |
14px (what is this?) (verify) |
Levobunolol (AK-Beta, Liquifilm, Betegan) is a non-selective beta blocker. It is used topically to manage glaucoma.
References
- Ishibashi T, Yokoi N, Kinoshita S (2003). "Comparison of the effects of topical levobunolol and timolol solution on the human ocular surface.". Cornea 22 (8): 709–15. PMID 14576520. doi:10.1097/00003226-200311000-00001.
- Ogasawara H, Yoshida A, Fujio N, Konno S, Ishiko S (1999). "[Effect of topical levobunolol on retinal, optic nerve head, and choroidal circulation in normal volunteers]". Nippon Ganka Gakkai Zasshi 103 (7): 544–50. PMID 10443129.
- Leung M, Grunwald J (1997). "Short-term effects of topical levobunolol on the human retinal circulation.". Eye 11 (3): 371–6. PMID 9373479. doi:10.1038/eye.1997.78.
|
Lua error in package.lua at line 80: module 'Module:Buffer' not found.